NSAID-induced gastropathy and H. pylori infection
- 문서 유형
- 연구출판물 · 저서
- 등재
- Scopus
- 저널
- Helicobacter pyloripp.395 · 2024
- 피인용
- Scopus 0
- FWCI (Scopus)
- 0
저자
- 김광하제1저자교신저자Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
초록
Gastrointestinal (GI) injury caused by nonsteroidal anti-infammatory drugs (NSAIDs) or Helicobacter pylori (H. pylori) occurs via different mechanisms. If these two factors coexist, the risk of GI injury increases independently and sometimes synergistically. In high-risk patients who require NSAID administration, examination of H. pylori infection is recommended followed by eradication therapy to prevent peptic ulcer in patients with confrmed H. pylori infection. A similar strategy is recommended for initial NSAID (excluding aspirin) users and long-term aspirin users with a history of peptic ulcer complications. In countries where the incidence of H. pylori infection is high, such as Korea, prevention and treatment strategies for NSAID users with H. pylori infection should differ from those in Western countries. Long-term multicenter studies that consider the current clinical situation are necessary in the future.
키워드
GastropathyHelicobacter pyloriNonsteroidal anti-infammatory drugsPeptic ulcer
식별자
- Scopus EID
- 2-s2.0-85202006549



로그인
연구물 목록으로